CNTB (Connect Biopharma Holdings) FFO


CNTB Connect Biopharma Holdings Ltd CNTB
7 GF Score
Price $2.13
! 3 Warning Signs
View Full Analysis

What is Connect Biopharma Holdings FFO?

FFO (Funds from operations) only applies to REITs.

CNTB
7GF Score
Connect Biopharma Holdings Ltd CNTB
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Connect Biopharma Holdings Business Description

Address 3580 Carmel Mountain Road, Suite 200, San Diego, CA, USA, 92130
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
7GF Score

Get the complete analysis for CNTB

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.13
Price